New, cheaper EpiPen rival approved by the FDA - Sách nói Miễn phí

U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.The Food and Drug Administration on Thursday approved Adamis Pharmaceuticals Corp.âs product, which should go on sale later this year. A new, cheaper rival to the EpiPen allergy shot has been approved by the Food and Drug Administration.As the AP's Ed Donahue reports, the product should go on sale later this year.